Direct-acting antiviral treatment of chronic HCV-infected patients on opioid substitution therapy: Still a concern in clinical practice?
Abstract
In Germany, direct-acting antiviral treatment of former or current drug users with or without opioid substitution therapy can achieve equally high sustained virological response rates as in patients with no history of drug use.
Keywords
hepatitis c
germany
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
treatment outcome
research support
non-u.s. gov't
adult
female
male
aged
middle aged
odds ratio
antiviral agents / therapeutic use*
chronic / complications
chronic / drug therapy*
registries
opiate substitution treatment*
Opioid-Related Disorders / complications
Opioid-Related Disorders / drug therapy*
Sustained Virologic Response*
pmid:29359361
doi:10.1111/add.14128
stefan christensen
peter buggisch
heiner wedemeyer
lost to follow-up*
Access
Citation
ID:
271443
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
271443
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet